{"id":464930,"date":"2021-03-25T07:33:11","date_gmt":"2021-03-25T11:33:11","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=464930"},"modified":"2021-03-25T07:33:11","modified_gmt":"2021-03-25T11:33:11","slug":"avicanna-to-participate-in-benzinga-biotech-small-cap-conference-and-the-virtual-life-sciences-investor-forum-both-taking-place-on-thursday-march-25th","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/avicanna-to-participate-in-benzinga-biotech-small-cap-conference-and-the-virtual-life-sciences-investor-forum-both-taking-place-on-thursday-march-25th\/","title":{"rendered":"Avicanna to Participate in Benzinga Biotech Small Cap Conference and the Virtual Life Sciences Investor Forum Both Taking Place on Thursday March 25th"},"content":{"rendered":"
\n

TORONTO, March 25, 2021 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna<\/strong>” or the “Company<\/strong>) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products is pleased to announce that Avicanna\u2019s Chief Executive Officer, Aras Azadian has been invited to present at the Benzinga Biotech Small Cap Conference (the \u201cBenzinga Conference<\/strong>\u201d) and the Virtual Life Sciences Investor Forum (the \u201cLife Sciences Investor Forum<\/strong>\u201d).<\/p>\n

Mr. Azadian will be presenting at the Benzinga Conference on March 25, 2021 at 10:40AM EST and will be participating in the panel discussion entitled \u201cThe Natural Solutions: Cannabis & Cannabinoids\u201d. The Benzinga Conference is focussed on highlighting companies in the biotech space who are helping to bring the world back to normalcy in the wake of the COVID-19 pandemic. To register and learn more about the Benzinga Conference visit https:\/\/www.benzinga.com\/events\/small-cap\/biotech\/<\/a>.<\/p>\n

Mr. Azadian will be presenting at the Life Sciences Investor Forum on March 25, 2021 at 2:00PM EST. The Life Sciences Investor Forum is the largest online investor conference series dedicated to the life sciences industry and features presentations from top executives and experts with live Q&A. To register and learn more about the Life Sciences Investor Forum visit https:\/\/www.lifesciencesinvestorforum.com\/events\/event-details\/agenda<\/a>.<\/p>\n

\n About Avicanna<\/strong>\n <\/p>\n

Avicanna is a diversified and vertically integrated Canadian biopharmaceutical company focused on the research, development and commercialization of plant-derived cannabinoid-based products for the global consumer, medical, and pharmaceutical market segments.<\/p>\n

Avicanna is an established leader in cannabinoid research and development, which it primarily conducts at its R&D headquarters in the Johnson & Johnson Innovation Centre, JLABS @ Toronto, Canada and in collaboration with leading Canadian academic and medical institutions. In addition to its developing pharmaceutical pipeline, Avicanna\u2019s team of experts have developed and commercialized several industry leading product lines, including:<\/p>\n